Anne M. Lachiewicz

University of North Carolina at Chapel Hill

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19”.

Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19

medRxiv(2022)10.1101/2022.09.22.22280245

N/A

0.464DataRank · unranked

9 citations

Eyal Kedar, Kevin J. Anstrom, Matthew W. McCarthy, Emily R. Ko, Patricia Segura Nunez +38 more

Prioritizing studies of COVID-19 and lessons learned

Journal of Clinical and Translational Science(2021)10.1017/cts.2021.784

N/A

0.385DataRank · unranked

12 citations

Patrick A. Flume, Nora G. Singer, Myron S. Cohen, Anne M. Lachiewicz, Amanda Cameron +7 more

Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center

PLoS ONE(2022)10.1371/journal.pone.0277707

N/A

0.165DataRank · unranked

2 citations

Matt Gilleskie, Chih-Huan Lu, Andrew Gilmore, Mariama Evans, Bridget Nelson +18 more

Retrospective analysis of multidrug-resistant clinical and environmental isolates for the presence of the colistin-resistance gene mcr-1

Infection Control and Hospital Epidemiology(2022)10.1017/ice.2022.8

N/A

0DataRank · unranked

0 citations

Mackenzie E. Collins, Anne M. Lachiewicz, Andy J. Koltun, Mark D. Sobsey, Elizabeth Christenson +3 more

Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study

UNC Libraries(2022)10.17615/27bq-xc46

N/A

0DataRank · unranked

0 citations

Heather Henderson, Alena J. Markmann, JoAnn Kuruc, Anne M. Lachiewicz, Luther A. Bartelt +16 more

Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM)

CHEST Critical Care(2024)10.1016/j.chstcc.2024.100095

N/A

0DataRank · unranked

0 citations

Miloni Shah, Tatyana Der, Derek D. Cyr, Hussein R. Al‐Khalidi, Christopher J. Lindsell +10 more

Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans Infections

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1847

N/A

0DataRank · unranked

52 citations

Luther A. Bartelt, Anne M. Lachiewicz, Kathleen Tompkins, Melissa B. Miller, Kevin Alby +14 more

Resource Utilization for COVID-19 Pneumonia in the ACTIV-1 Trial: A Secondary Data Analysis

UNC Libraries(2024)10.17615/stmd-4q47

N/A

0DataRank · unranked

0 citations

Derek D. Cyr, Miloni Shah, Anne M. Lachiewicz, Andreas Schmid, Martín Maillo +11 more

Timeline of health care–associated infections and pathogens after burn injuries

UNC Libraries(2020)10.17615/4xz8-tz08

N/A

0DataRank · unranked

0 citations

Bruce A. Cairns, William A. Rutala, Lauren DiBiase, Robert Maile, Sonia Napravnik +7 more

Outcomes of convalescent plasma with defined high- versus lower-neutralizing antibody titers against SARS-CoV-2 among hospitalized patients: CoronaVirus Inactivating Plasma (CoVIP), double-blind phase 2 study

medRxiv(2022)10.1101/2022.04.29.22274387

N/A

0DataRank · unranked

2 citations

Alena J. Markmann, Bridget Nelson, Jessica Keys, Heather Root, Heather Henderson +16 more